FILTER
FILTERED INTERVIEW RESULTS
Rajiv Anand
FOUNDER AND CEO, QUARTIC.AI
Quartic AI explains how artificial intelligence and machine learning should be applied in life sciences.
Rajiv Anand
FOUNDER & CEO, QUARTIC AI
"Much of the focus of tech development has been for people in IT and data science. This creates a big barrier to adoption for chemists, biologists or chemical engineers, it is unsustainable. Overcoming those two barriers is the inspiration behind Quartic.ai."
Peter Staartjes
CEO, ANDINO HOLDINGS
Andino Holdings comments on the factors influencing the chemical distribution market in Latin America for 2020.
Ricardo Cuetos
VP AMERICAS STANDARD PRODUCTS, INEOS STYROLUTION
INEOS Styrolution explains the current market dynamics of the America’s and how it’s various units are coping.
Paul Hennessey
SENIOR VICE PRESIDENT – OPERATIONS, QUALITY AND TECHNICAL SERVICES, ADVANTICE HEALTH
Advantice Health provides consumer health care products and is focused on building a number of brands.
Dr. Jeffrey Reingold
COO, CONTRACT PHARMACAL CORP
CPC, a full-service contract manufacturer in the US, comments on the current business environment.
Roel Schaapveld
CEO, INTERNA TECHNOLOGIES
InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer.
Anthony Capobianco
FOUNDER AND PRESIDENT, STEMSYNERGY THERAPEUTICS
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer.
Manni Kantipudi & Dr. Ramesh Subramanian
CHIEF EXECUTIVE OFFICER & CHIEF COMMERCIAL OFFICER, GVK BIO
GVK BIO is a global contract research and development organization (CRDO) providing drug discovery and development services to the biopharma industry.
Ed Ikeguchi
CEO, AICURE
AiCure is an AI and advanced data analytics company targeting the health industry.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
